Home Newsletters Mammary Cell News Dinaciclib Inhibits the Stemness of Two Subtypes of Human Breast Cancer Cells...

Dinaciclib Inhibits the Stemness of Two Subtypes of Human Breast Cancer Cells by Targeting the FoxM1 and Hedgehog Signaling Pathway

By
Justin.choi
-
0
Investigators aimed to examine the stemness‑inhibitory effects of dinaciclib in MCF‑7 and HCC‑1806 breast cancer cells.
[Oncology Reports]

Sorry, but the selected Zotpress account can't be found.

Abstract

RELATED ARTICLES

Exit mobile version